Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ready to Use: DASGIP and Mobius CellReady 3L Bioreactor

24.02.2010
Advanced Control of Disposable Benchtop Technology
DASGIP strengthens its market position by combining disposable benchtop bioreactors with the DASGIP technology. Thanks to the unique modularity of the DASGIP Parallel Bioreactor System the Mobius CellReady 3L bioreactor can be integrated seamlessly into DASGIP’s control system.

In this manner, DASGIP combines the familiar powerful process control with the advantages of disposable technology. The CellReady bioreactor is a single-use stirred tank bioreactor for cell culture process development. The disposable bioreactor eliminates the need to clean and autoclave, thus it accelerates preparation and post-processing time.

“The integration of single-use benchtop bioreactors into our DASGIP Parallel Bioreactor System enhances flexibility of users which is decisive in the dynamic laboratory equipment market.” explains Dr. Thomas Drescher, Chief Executive Officer at DASGIP. “Combining the Parallel Bioreactor System and the CellReady Bioreactor we make advanced process control available for single-use reactors at benchtop scale. Thereby disposable bioreactors deliver a higher degree of reliability, scalability and reproducibility. Due to the parallel design up to eight disposable vessels can be operated at the same time and serve the users with rapid and accurate results.”

Hence, operators of disposable bioreactors are free to add the well-known DASGIP monitoring and control units as their application requires: mass flow controlled gas mixing, variable speed controlled pumps and monitoring of pH and dissolved oxygen are available, advanced inline measurements such as off-gas analysis or optical density monitoring alike. Set-points and profiles, such as agitation rate, temperature, pH, and DO can be accessed through the DASGIP Control user interface even online. An integrated historian and 21 CFR Port 11 compliant one-click process reports alleviate documentation tremendously.

For more information visit our website at: www.dasgip.com


About DASGIP: DASGIP AG develops and manufactures technologically advanced Parallel Bioreactor Systems for the cultivation of microbial, plant, animal and human cells at bench top scale. Process engineers, scientists and product developers from biotechnological, pharmaceutical and chemical companies as well as research institutions use DASGIP Parallel Bioreactor Systems for their biotechnological processes and benefit from increased productivity, high reproducibility, and ease of scale up, resulting in accelerated product development cycles. DASGIP is located in Juelich (Germany) and Shrewsbury MA (USA)

Contact: Martin Grolms, Tel: +49 2461.980 -121, m.grolms@dasgip.de

Martin Grolms | DASGIP AG
Further information:
http://www.dasgip.de

Further reports about: CellReady Control DASGIP Mobius bioreactor equipment market human cell single-use reactors

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>